Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global equine healthcare market, 2017 2023 (USD Million)
2.2. Global equine healthcare market: snapshot
Chapter 3. Equine Healthcare Market Market Dynamics
3.1. Introduction
3.2. Market Drivers
3.2.1. Global equine healthcare market drivers: impact analysis
3.2.2. Rising incidence of equine infections
3.2.3. Initiatives by equine healthcare organizations and market participants
3.3. Market Restraints
3.3.1. Global equine healthcare market restraints: impact analysis
3.3.2. The decline in global equine population
3.4. Opportunities
3.4.1. The rise in demand for pet insurance
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. The threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis, by product type segment
3.6.2. Market attractiveness analysis, by diseases type segment
3.6.3. Market attractiveness analysis, by distribution channel segment
3.6.4. Market attractiveness analysis, by regional segment
Chapter 4. Global Equine Healthcare Market Competitive Landscape
4.1. Company market share analysis
4.1.1. Global equine healthcare market: company market share, 2017
4.2. Strategic development
4.2.1. Acquisitions mergers
4.2.2. New therapy launch
4.2.3. Agreements, partnerships, collaborations and joint ventures
4.2.4. Research and development and regional expansion
4.3. Price trend analysis
Chapter 5. Global Equine Healthcare Market Product Type Analysis
5.1. Global equine healthcare market: Product type overview
5.1.1. Global equine healthcare market revenue share, by product type, 2017 and 2023
5.2. Drug Type
5.2.1. Global equine healthcare market for drug type, 2017 2023 (USD Million)
5.2.1.1. Anti-Infectives
5.2.1.1.1. Global anti-infectives market, 2016 2022 (USD Million)
5.2.1.2. Anti-Inflammatory
5.2.1.2.1. The global anti-inflammatory market, 2016 2022 (USD Million)
5.2.1.3. Parasiticides
5.2.1.3.1. Global parasiticides market, 2016 2022 (USD Million)
5.2.1.4. Others
5.2.1.4.1. Global others market, 2016 2022 (USD Million)
5.3. Vaccine Type
5.3.1. Global equine healthcare market for vaccine type, 2017 2023 (USD Million)
5.3.1.1. Inactivated
5.3.1.1.1. Global inactivated market, 2016 2022 (USD Million)
5.3.1.2. Live Attenuated
5.3.1.2.1. Global live attenuated market, 2016 2022 (USD Million)
5.3.1.3. Recombinant
5.3.1.3.1. Global recombinant market, 2016 2022 (USD Million)
5.3.1.4. Others
5.3.1.4.1. Global others market, 2016 2022 (USD Million)
5.4. Supplemental Feed Additives
5.4.1. Global equine healthcare market for supplemental feed additives, 2017 2023 (USD Million)
Chapter 6. Global Equine Healthcare Market Diseases Type Analysis
6.1. Global equine healthcare market: Diseases type overview
6.1.1. Global equine healthcare market revenue share, by disease type, 2017 and 2023
6.2. West Nile Virus
6.2.1. Global equine healthcare market for west nile virus, 2017 2023 (USD Million)
6.3. Equine Influenza
6.3.1. Global equine healthcare market for equine influenza, 2017 2023 (USD Million)
6.4. Equine Herpes Virus
6.4.1. Global equine healthcare market for equine herpes virus, 2017 2023 (USD Million)
6.5. Potomac Horse Fever
6.5.1. Global equine healthcare market for potomac horse fever, 2017 2023 (USD Million)
6.6. Others
6.6.1. Global equine healthcare market for others, 2017 2023 (USD Million)
Chapter 7. Global Equine Healthcare Market Distribution Channel Analysis
7.1. Global equine healthcare market: distribution channel overview
7.1.1. Global equine healthcare market revenue share, by distribution channel, 2017 and 2023
7.2. Veterinary Hospitals and Clinics
7.2.1. Global equine healthcare market for veterinary hospitals and clinics, 2017 2023 (USD Million)
7.3. Retail Pharmacies and Drug Stores
7.3.1. Global equine healthcare market for retail pharmacies and drug stores, 2017 2023 (USD Million)
7.4. Others
7.4.1. Global equine healthcare market for others, 2017 2023 (USD Million)
Chapter 8. Global Equine Healthcare Market Regional Segment Analysis
8.1. Global equine healthcare market: regional overview
8.1.1. Global equine healthcare market revenue share, by region, 2017 and 2023
8.2. North America
8.2.1. North America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.2.2. North America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.2.3. North America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.2.4. U.S.
8.2.4.1. U.S. equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.2.4.2. U.S. equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.2.4.3. U.S. equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.2.5. Rest of North America
8.2.5.1. Rest of North America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.2.5.2. Rest of North America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.2.5.3. Rest of North America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.3. Europe
8.3.1. Europe equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.3.2. Europe equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.3.3. Europe equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.3.4. U.K.
8.3.4.1. U.K. equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.3.4.2. U.K. equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.3.4.3. U.K. equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.3.5. Germany
8.3.5.1. Germany equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.3.5.2. Germany equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.3.5.3. Germany equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.3.6. France
8.3.6.1. France equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.3.6.2. France equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.3.6.3. France equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.3.7. Rest of Europe
8.3.7.1. Rest of Europe equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.3.7.2. Rest of Europe equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.3.7.3. Rest of Europe equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.4.2. Asia Pacific equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.4.3. Asia Pacific equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.4.4. China
8.4.4.1. China equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.4.4.2. China equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.4.4.3. China equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.4.5. Japan
8.4.5.1. Japan equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.4.5.2. Japan equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.4.5.3. Japan equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.4.6. India
8.4.6.1. India equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.4.6.2. India equine healthcare market revenue, by diseases, 2017 2023 (USD Million)
8.4.6.3. India equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.4.7. Rest of Asia Pacific
8.4.7.1. Rest of Asia Pacific equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.4.7.2. Rest of Asia Pacific equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.4.7.3. Rest of Asia Pacific equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.5. Latin America
8.5.1. Latin America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.5.2. Latin America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.5.3. Latin America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.5.4. Brazil
8.5.4.1. Brazil equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.5.4.2. Brazil equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.5.4.3. Brazil equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.5.5. Mexico
8.5.5.1. Mexico equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.5.5.2. Mexico equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.5.5.3. Mexico equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.5.6. Rest of Latin America
8.5.6.1. Rest of Latin America equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.5.6.2. Rest of Latin America equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.5.6.3. Rest of Latin America equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.6.2. Middle East and Africa equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.6.3. Middle East and Africa equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Saudi Arabia equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.6.4.2. Saudi Arabia equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.6.4.3. Saudi Arabia equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.6.5. UAE
8.6.5.1. UAE equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.6.5.2. UAE equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.6.5.3. UAE equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.6.6. South Africa
8.6.6.1. South Africa equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.6.6.2. South Africa equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.6.6.3. South Africa equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
8.6.7. Rest of Middle East and Africa
8.6.7.1. Rest of Middle East and Africa equine healthcare market revenue, by product type, 2017 2023 (USD Million)
8.6.7.2. Rest of Middle East and Africa equine healthcare market revenue, by diseases type, 2017 2023 (USD Million)
8.6.7.3. Rest of Middle East and Africa equine healthcare market revenue, by distribution channel, 2017 2023 (USD Million)
Chapter 9. Company Profiles
9.1. Bayer AG (Bayer Animal Health)
9.1.1. Overview
9.1.2. Financials
9.1.3. Therapy portfolio
9.1.4. Business strategy
9.1.5. Recent developments
9.2. Boehringer Ingelheim
9.2.1. Overview
9.2.2. Financials
9.2.3. Therapy portfolio
9.2.4. Business strategy
9.2.5. Recent developments
9.3. Ceva Sant Animale
9.3.1. Overview
9.3.2. Financials
9.3.3. Therapy portfolio
9.3.4. Business strategy
9.3.5. Recent developments
9.4. Eli Lilly and Company (Elanco)
9.4.1. Overview
9.4.2. Financials
9.4.3. Therapy portfolio
9.4.4. Business strategy
9.4.5. Recent developments
9.5. Equine Products U.K. Ltd.
9.5.1. Overview
9.5.2. Financials
9.5.3. Therapy portfolio
9.5.4. Business strategy
9.5.5. Recent developments
9.6. Merck Co. (Merck Animal Health)
9.6.1. Overview
9.6.2. Financials
9.6.3. Therapy portfolio
9.6.4. Business strategy
9.6.5. Recent developments
9.7. Sanofi (Merial)
9.7.1. Overview
9.7.2. Financials
9.7.3. Therapy portfolio
9.7.4. Business strategy
9.7.5. Recent developments
9.8. Purina Animal Nutrition LLC]
9.8.1. Overview
9.8.2. Financials
9.8.3. Therapy portfolio
9.8.4. Business strategy
9.8.5. Recent developments
9.9. Vetoquinol S.A.
9.9.1. Overview
9.9.2. Financials
9.9.3. Therapy portfolio
9.9.4. Business strategy
9.9.5. Recent developments
9.10. Zoetis
9.10.1. Overview
9.10.2. Financials
9.10.3. Therapy portfolio
9.10.4. Business strategy
9.10.5. Recent developments
